Rhodococcus equi is the primary bacterial cause of severe bronchopneumonia in 1 to 5-month-old foals, and NAVLE® questions frequently test your ability to quickly identify it. The disease often has a recognizable pattern of presentation that emerges before culture results are available. If you understand how to read the clinical signs and clinicopathology clues, you will consistently and confidently identify R. equi in various exam scenarios.
How to Recognize R. equi Before Culture Results
Most foals develop clinical pneumonia between 1 and 5 months, but classic R. equi cases cluster around 3-4 months as passive immunity wanes.
R. equi infections can quickly become life-threatening once the affected foal crosses a threshold into decompensation. Early clinical signs are nonspecific (e.g., anorexia, fever, lethargy). As the disease progresses, however, affected foals struggle with progressive respiratory compromise, presenting with nostril flare and abdominal breathing. Cough and nasal discharge are less consistent findings.
Use thoracic ultrasound and radiography to identify pulmonary consolidation and/or abscessation. Mediastinal lymphadenopathy and nodular lung lesions in a foal 1 to 5 months of age are classic clinical signs of R. equi pneumonia.
Inflammatory Markers That Narrow Your Differential
The NAVLE® frequently tests your ability to interpret CBCs and acute phase proteins. Affected foals have:
- Neutrophilic leukocytosis
- Dramatically elevated fibrinogen, increased globulins
- Serum amyloid A (SAA) increases are variable and nonreliable
Viral pneumonia, intestinal parasitism, and equine proliferative enteropathy (caused by Lawsonia intracellularis) may affect the same age group and at first have similar signs of lethargy/anorexia (+/- fever), but these clinicopathologic lab findings are not consistent with those differentials. Tracheal wash is a key diagnostic, revealing pleomorphic gram-positive coccobacilli, an immediate signal that R. equi is the top differential in a young foal.
Submit the sample for both culture/sensitivity and PCR for the virulence-associated protein A (VapA) gene. Because R. equi is ubiquitous in the environment, and subclinical infections may not require treatment, the VapA gene proves any cultured R. equi is actually causing the infection.
Therapy that Targets the Source
Most foals require combination therapy with a macrolide antibiotic (best: clarithromycin) and rifampin, which work synergistically, plus supportive care, and anti-inflammatories as needed. This regimen targets intracellular bacteria and penetrates abscesses, which are common in R. equi pneumonia. Treat until consistent improvement of abnormalities on radiographs, and resolution of hematology/proteins and clinical signs (treatment regimen lasts 4-12 weeks). Hyperthermia, diarrhea, and tachypnea are possible side effects of these antibiotics.
Successful treatment of R. equi pneumonia requires ongoing evaluation.
Watch for Extrapulmonary Manifestations
R. equi can concurrently (or solely) affect the GI tract, mesenteric lymph nodes, abdominal organs, synovial structures, and bone (from most to least common) although infection or inflammation is possible anywhere. Up to 50% of foals show intestinal involvement at necropsy without any specific clinical signs. Prognosis with extrapulmonary manifestations is worse than for bronchopneumonia.
See the Pattern, Make the Diagnosis
R. equi pneumonia is a pattern-recognition disease: the age, clinical signs, tracheal wash cytology, and clinical pathology findings (+ diagnostic imaging, when possible) point strongly toward the correct diagnosis before confirmatory tests return. Strengthen your ability to connect these clinical and clinicopathologic clues, and you will move through NAVLE® questions with greater speed, accuracy, and confidence.
More from Zuku:
- Master NAVLE® concepts
- Subscribe to the Question of the Day to receive a NAVLE® question delivered to your inbox daily
- View the Study Strategy video series
- Review the Equine ECG Made Simple: How to Recognize Second-Degree AV Block and Differentiate from Atrial Fibrillation blog
- Review The Productivity Trap: Why More Studying Can Hurt Your NAVLE® Score blog
